Literature DB >> 28534370

Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.

Yongjun Qi1, Jingwei Fu.   

Abstract

PURPOSE: To investigate the relationship between coagulation function and prognosis of non-small cell lung cancer (NSCLC) patients.
METHODS: 539 patients who were admitted to our hospital for the first time from December 2008 to December 2013 and pathologically diagnosed as NSCLC were enrolled in this study (study group), while 80 healthy persons served as controls (control group). Morning fasting venous blood samples were collected for coagulation function indexes, such as prothrombin time (PT), prothrombin time activity (PTA), international normalized ratio (INR), activated partial thromboplastin time (APTT), fibrinogen (Fib), D-dimer (D-D) and platelet count (PLT) and the coagulation function and survival rate were compared.
RESULTS: All coagulation function indexes (PT, PTA, INR, APTT, Fib, D-D and PLT) in the study group patients were significantly different compared with the control group. PTA and APTT in the control group were longer compared with the study group, and PT in the study group was significantly longer compared with control group. No obvious correlation between age and the coagulation function indexes was found. Gender correlated significantly to PT, PTA, INR and APTT. Fib and PLT levels in stage I-II NSCLC patients were significantly higher than those in stage III-IV NSCLC patients. Fib level increased, PT and INR were prolonged and PTA declined significantly and patient survival rate was significantly reduced.
CONCLUSION: Most NSCLC patients have abnormal coagulation function, and each coagulation index may be used to judge the prognosis as well as survival of such patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534370

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  16 in total

1.  Risk factor analysis of bone metastasis in patients with non-small cell lung cancer.

Authors:  Yang Li; Chongqing Xu; Qiquan Yu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  The association between plasma fibrinogen levels and lung cancer: a meta-analysis.

Authors:  Ke Zhang; Ye Xu; Shanyue Tan; Xueyan Wang; Mulong Du; Lingxiang Liu
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

3.  Preoperative D-dimer level is an independent prognostic factor for non-small cell lung cancer after surgical resection: a systematic review and meta-analysis.

Authors:  Han-Yu Deng; Xi Zheng; Rui Jiang; Rui-Lan Wang; Jie Zhou; Xiao-Ming Qiu
Journal:  Ann Transl Med       Date:  2019-08

4.  [Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].

Authors:  X H Liao; R F Wang; M Liu; X Q Chen; Y Xiong; L Nong; L Yin; B Y Zhang; Y J DU
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-10-20

5.  Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.

Authors:  Kunihiro Asanuma; Tomoki Nakamura; Tomohito Hagi; Takayuki Okamoto; Kouji Kita; Koichi Nakamura; Yumi Matsuyama; Keisuke Yoshida; Yumiko Asanuma; Akihiro Sudo
Journal:  BMC Cancer       Date:  2021-04-07       Impact factor: 4.430

6.  The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.

Authors:  Nan-Nan Bian; Xin-Yu Shi; Hong-Yu Qi; Xin Hu; Yang Ge; Guang-Yu An; Guo-Sheng Feng
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Association between short-term heart rate variability and blood coagulation in patients with breast cancer.

Authors:  Lingling Wang; Jingfeng Wang; Peng Li; Xiangzhi Wang; Shuang Wu; Bo Shi
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

8.  Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimer.

Authors:  Yuanshan Yao; Haibo Shen; Yinjie Zhou; Zhenhua Yang; Hongbo Huang
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

9.  The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.

Authors:  Qiu-Fang Gao; Jia-Cong Qiu; Xiao-Hong Huang; Yan-Mei Xu; Shu-Qi Li; Fan Sun; Jing Zhang; Wei-Ming Yang; Qing-Hua Min; Yu-Huan Jiang; Qing-Gen Chen; Lei Zhang; Xiao-Zhong Wang; Hou-Qun Ying
Journal:  Cancer Cell Int       Date:  2018-10-03       Impact factor: 5.722

10.  Elevated Pretreatment Fibrinogen-to-Lymphocyte Percentage Ratio Predict Tumor Staging and Poor Survival in Non-Small Cell Lung Cancer Patients with Chemotherapy or Surgery Combined with Chemotherapy.

Authors:  Meifang Liu; Jie Yang; Lagen Wan; Rui Zhao
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.